FDA Lifts Clinical Hold on Investigational Lenacapavir for the Treatment and Prevention of HIV

FOSTER CITY, Calif.--(BUSINESS WIRE)--May 16, 2022-- Gilead Sciences, Inc. (Nasdaq: GILD) today announced the U.S. Food and Drug Administration (FDA) has lifted the clinical hold placed on the company’s Investigational New Drug Application...
Source: Drugs.com - Clinical Trials - Category: Pharmaceuticals Source Type: clinical trials